From: Metformin-repressed miR-381-YAP-snail axis activity disrupts NSCLC growth and metastasis
Characteristics | No. of patients, N = 60 (%) | P value |
---|---|---|
Patients Parameter | ||
 Age (years) | 0.542 | |
 Average [range] | 53 [25–81] |  |
  < 55 | 21 (35.0) |  |
  ≥ 55 | 39 (65.0) |  |
Gender | 0.881 | |
 Male | 33 (55.0) |  |
 Female | 27 (45.0) |  |
Tumor Characteristics | ||
 Tumor size (cm) | 0.004** | |
  < 4 | 9 (15.0) |  |
  ≥ 4 | 51 (85.0) |  |
Differentiation | 0.062 | |
 Poor | 39 (65.0) |  |
 Well-moderate | 21 (35.0) |  |
Lymph node metastasis | 0.034* | |
 N- | 10 (16.7) |  |
 N+ | 50 (83.3) |  |
Distant metastasis | 0.039* | |
 M- | 15 (25.0) |  |
 M+ | 45 (75.0) |  |
miR-381 level | ||
 high | 5 (8.3) | 0.821 |
 median | 6 (10.0) | 0.093 |
 low | 49 (81.7) | 0.002** |